Should clopidogrel be discontinued before laparoscopic cholecystectomy?

Area of Science:

• Surgical Management
• Pharmacology
• Cardiovascular Medicine

Background:

• Perioperative management of clopidogrel is controversial.
• Clopidogrel is an antiplatelet medication.
• Laparoscopic cholecystectomy is a common surgical procedure.

Purpose of the Study:

• To evaluate the safety of continuing clopidogrel during laparoscopic cholecystectomy.
• To compare outcomes between patients on clopidogrel and a control group.

Main Methods:

• Retrospective review of 100 patients undergoing laparoscopic cholecystectomy.
• Matched patients on clopidogrel with a control group.
• Compared estimated blood loss, operative time, length of stay, and 30-day morbidity.

Main Results:

• No significant differences in blood loss, operative time, length of stay, or 30-day morbidity between groups.
• Average blood loss was 50 mL in the clopidogrel group and 47 mL in the control group.
• Patient demographics and comorbidities were similar between groups.

Conclusions:

• Continuing clopidogrel during laparoscopic cholecystectomy is safe.
• The medication does not increase surgical risks.
• Perioperative management of clopidogrel can be individualized.